FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis

Journal of Gene Medicine

Volumn 11, Issue 11, 2009, Pages 1064-1070

  Kang, Youmin ^a   Zhao, Jia ^a   Liu, Yue ^a   Chen, Aoshuang ^b   Zheng, Guoxing ^b   Yu, Yang ^a   Mi, Jianjie ^a   Zou, Qiang ^a   Wang, Bin ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Adjuvant; DNA vaccination; EAE; FK506; Prevention; Tolerance

Indexed keywords

CD4 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; TACROLIMUS;

ADJUVANT THERAPY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DNA IMMUNIZATION; FEMALE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH17 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; MYELIN-ASSOCIATED GLYCOPROTEIN; TACROLIMUS; VACCINATION; VACCINES, DNA;

ANIMALIA; MUS;

EID: 72949101620     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1387     Document Type: Article

References (30)

1. Ferrera F, La Cava A, Rizzi M, Hahn, BH, Indiveri F, Filaci G. Gene vaccination for the induction of immune tolerance. Ann NY Acad Sci 2007; 1110: 99-111.
2. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Annu Rev Immunol 1997; 15: 617-648.
3. Abe M, Thomson AW. Influence of immunosuppressive drugs on dendritic cells. Transpl Immunol 2003; 11: 357-365.
4. Ulmer JB, Wahren B, Liu MA. Gene-based vaccines: recent technical and clinical advances. Trends Mol Med. 2006; 12: 216-222.
5. Powell MB, Mitchell D, Lederman J, et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic proteinspecific T cell clones correlates with encephalitogenicity. Int Immunol 1990; 2: 539-544.
6. Lobell A, Weissert R, Eltayeb S, et al. Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptideinduced experimental autoimmune encephalomyelitis involves a T1-biased immune response. J Immunol 2003; 170: 1806-1813.
7. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl JMed 2000; 343: 938-952.
8. Ruiz PJ, GarrenI H, Ruiz IU, et al. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. J Immunol 1999; 162: 3336-3341.
9. Lobell A, Weissert R, Storch MK, et al. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J Exp Med 1998; 187: 1543-1548.
10. Waisman A, Ruiz PJ, Hirschberg DL, et al. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med 1996; 2: 899-905.
11. Allison AC. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 2000; 47: 63-83.
12. Clipstone NA, Crabtree GR. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992; 357: 695-697.
13. O'Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O'Neill EA. FK-506-and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 1992; 357: 692-694.
14. Lee Y-R, Yang I-H, Lee Y-H, et al. Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood 2005; 105: 3951-3955.
15. Matsue H, Yang C, Matsue K, Edelbaum D, Mummert M, Takashima A. Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T Cell interaction during antigen presentation. J Immunol 2002; 169: 3555-3564.
16. Kang Y, Xu L, Wang B, Chen A, Zheng G. Cutting edge: immunosuppressant as adjuvant for tolerogenic immunization. J Immunol 2008; 180: 5172-5176.
17. JinH, Li Y, Ma Z, et al. Effect of chemical adjuvants on DNA vaccination. Vaccine 2004; 22: 2925-2935.
18. Su B, Wang J, Wang X, et al. The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination. Vaccine 2008; 26: 5111-5122.
19. Kang Y, Jin H, Zheng G, et al. The adjuvant effect of levamisole on killed viral vaccines. Vaccine. 2005; 23: 5543-5550.
20. Kang Y, Jin H. Zheng G, et al. Co-inoculation of DNA and protein vaccines induces antigen-specific T cell suppression. Biochem Biophys Res Commun 2007; 353: 1034-1039.
21. Tompkins SM Padilla J, Dal Canto MC, et al. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J Immunol 2002; 168: 4173-4183.
22. Jonuleit H, Schmitt E, Schuler G, Knop J and Enk AH. Induction of Interleukin 10-producing, Nonproliferating CD4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells. J. Exp. Med. 2000; 192: 1213-1222.
23. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C and Bhardwaj N. Antigen-specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells. J. Exp. Med. 2001; 193: 233-238.
24. Imai A, Sahara H, Tamura Y, Jimbow K, Saito T, Ezoe K, Yotsuyanagi T and Sato N. Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51. Eur J Immunol 2007; 37: 1730-1738.
25. Zheng W and Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89: 587-596.
26. Mosmann TR, Bond MW, Coffman RL, Ohara J and Paul WE. T-cell and must cell lines respond to B-cell stimulatory factor 1. Proceedings of the National Academy of Sciences of the United States of America 1986; 83: 5654-5658.
27. Kolls JK and Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-476.
28. Weaver CT. Th17: The ascent of a new effector T-cell subset. Preface. Eur J Immunol 2009; 39: 634-636.
29. Mills KH. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 2008; 38: 2636-2649.
30. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM and Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132.